Recent Developments in Glycine Transporter-1 Inhibitors

被引：9
作者：
Cioffi, Christopher L. [1 ]
Liu, Shuang [1 ]
Wolf, Mark A. [1 ]
机构：
[1] AMRI, Albany, NY 12203 USA
来源：
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 45 | 2010年 / 45卷
关键词：
SELECTIVE GLYT1 INHIBITORS; PHENCYCLIDINE-INDUCED HYPERACTIVITY; HALOPERIDOL-INDUCED CATALEPSY; RECEPTOR-MEDIATED RESPONSES; IN-VIVO; SUBSTITUTED SPIROPIPERIDINES; DISCOVERY; SCHIZOPHRENIA; TYPE-1; POTENT;
D O I：
10.1016/S0065-7743(10)45002-2
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：19 / 35
页数：17
相关论文
共 50 条
  • [41] Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain
    Dohi, Toshihiro
    Morita, Katsuya
    Kitayama, Tomoya
    Motoyama, Naoyo
    Morioka, Norimitsu
    PHARMACOLOGY & THERAPEUTICS, 2009, 123 (01) : 54 - 79
  • [42] Glycine Transporter Type I (GlyT1) Inhibitor, Bitopertin: A Journey from Lab to Patient
    Pinard, Emmanuel
    Borroni, Edilio
    Koerner, Annette
    Umbricht, Daniel
    Alberati, Daniela
    CHIMIA, 2018, 72 (7-8) : 477 - 484
  • [43] Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 mice
    Kopec, Karla
    Flood, Dorothy G.
    Gasior, Maciej
    McKenna, Beth Ann W.
    Zuvich, Eva
    Schreiber, Justin
    Salvino, Joseph M.
    Durkin, John T.
    Ator, Mark A.
    Marino, Michael J.
    BIOCHEMICAL PHARMACOLOGY, 2010, 80 (09) : 1407 - 1417
  • [44] Demonstration of vesicular glutamate transporter-1 in corticotroph cells in the anterior pituitary of the rat
    Kocsis, Zsuzsa S.
    Molnar, Csilla S.
    Watanabe, Masahiko
    Daneels, Guy
    Moechars, Dieder
    Liposits, Zsolt
    Hrabovszky, Erik
    NEUROCHEMISTRY INTERNATIONAL, 2010, 56 (03) : 479 - 486
  • [45] Inhibition of Glycine Transporter 1: The Yellow Brick Road to New Schizophrenia Therapy?
    Singer, Philipp
    Dubroqua, Sylvain
    Yee, Benjamin K.
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (26) : 3771 - 3787
  • [46] Vesicular monoamine transporter-1 (VMAT-1) mRNA and immunoreactive proteins in mouse brain
    Ashe, Karen M.
    Chiu, Wan-Ling
    Khalifa, Ahmed M.
    Nicolas, Antoine N.
    Brown, Bonnie L.
    De Martino, Randall R.
    Alexander, Clayton P.
    Waggener, Christopher T.
    Fischer-Stenger, Krista
    Stewart, Jennifer K.
    NEUROENDOCRINOLOGY LETTERS, 2011, 32 (03) : 253 - 258
  • [47] Evolution of HIV-1 reverse transcriptase and integrase dual inhibitors: Recent advances and developments
    Gill, Muhammad Shoaib Ali
    Hassan, Sharifah Syed
    Ahemad, Nafees
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 179 : 423 - 448
  • [48] Loss of Glycine Transporter 1 Causes a Subtype of Glycine Encephalopathy with Arthrogryposis and Mildly Elevated Cerebrospinal Fluid Glycine
    Kurolap, Alina
    Armbruster, Anja
    Hershkovitz, Tova
    Hauf, Katharina
    Mory, Adi
    Paperna, Tamar
    Hannappel, Ewald
    Tal, Galit
    Nijem, Yusif
    Sella, Ella
    Mahajnah, Muhammad
    Ilivitzki, Anat
    Hershkovitz, Dov
    Ekhilevitch, Nina
    Mandel, Hanna
    Eulenburg, Volker
    Baris, Hagit N.
    AMERICAN JOURNAL OF HUMAN GENETICS, 2016, 99 (05) : 1172 - 1180
  • [49] Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2020-present)
    Shi, Xiaoyu
    Zhao, Tong
    da Silva Jr, Edeildo Ferreira
    Zhang, Jian
    Xu, Shujing
    Zhan, Peng
    Gao, Shenghua
    Liu, Xinyong
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2022, 32 (12) : 1175 - 1184
  • [50] Glycine transport inhibitors for the treatment of schizophrenia: Symptom and disease modification
    Javitt, Daniel C.
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2009, 12 (04) : 468 - 478
12345